The reaction of ethyl 4′-amino-1′H-spiro[cycloheptane-1, 2′-naphthalene]-3′-carboxylate with phenethylisothiocyanate followed by cyclization of the intermediate thiourea synthesized 3-phenethyl-2-thioxo-2,3-dihydro-1H-spiro[benzo[h]quinazoline-5,1′-cycloheptane]-4(6H)-one (2-thioxobenzo[h]quinazoline), which was alkylated in the presence of alkali into 2-alkylthio-substituted 3-phenethyl-3H-spiro[benzo[h]quinazoline-5,1′-cycloheptane]-4(6H)-ones. 2-Thioxobenzo[h]quinazoline was converted to 2-hydrazinyl-3-phenethyl-3H-spiro[benzo[h]quinazoline-5,1′-cycloheptane]-4(6H)-one, condensation of which with carbon disulfide resulted in 1-mercapto-4-phenethyl-4H-spiro[benzo[h][1,2,4]triazolo[4,3-a]quinazoline-6,1′-cycloheptane]- 5(7H)-one. A study of the antitumor properties of the synthesized compounds showed that some of them were active (37 – 66%) against sarcoma 180. The synthesized compounds possessed weak bacteriostatic activity against Gram-positive (St. aureus 209 P and 1) and Gram-negative microorganisms (Sh. flexneri 6858 and E. coli 0 – 55).
Similar content being viewed by others
References
H. K. Maurya, M. Hasanain, S. Singh, et al., RSC Adv., 22(6), 18607 – 18618 (2016).
L. Wu and Ch. Zhang, RSC Adv., 34(6), 28555 – 28562 (2016); doi https://doi.org/10.1039/C6RA03323G.
A. K. Keshari, A. K. Singh, V. Raj, et al., Drug Des., Dev. Ther., 11, 1623 – 1642 (2017); doi https://doi.org/10.2147/DDDT.S136692.
A. K. Keshari, A. K. Singh, U. Kumar, et al., Drug Des., Dev. Ther., 11, 2981 – 2995 (2017).
L.Wu, Ch. Zhang, and W. Li, Bioorg. Med. Chem. Lett., 23(17), 5002 – 5005 (2013).
H. Ohtomo, T. Tagata, K. Sasaki, et al., Tetrahedron, 63(51), 12541 – 12546 (2007).
N. Sati, S. Kumar, and M. S. M. Rawat, Indian J. Pharm. Sci., 71(5), 572 – 575 (2009).
Y. A. Mohamed, A. G. Amr, S. F. Mohamed, et al., J. Chem. Sci., 124(3), 693 – 702 (2012).
M. Sahoo, L. Jena, S. Daf, et al., Genomics Inf., 14(3), 104 – 111 (2016); doi https://doi.org/10.5808/GI.2016.14.3.104.
R. Gupta and R. P. Chaudhary, Phosphorus, Sulfur Silicon Relat. Elem., 187(6), 735 – 742 (2012).
R. Gali, J. Banothu, M. Porika, et al., Bioorg. Med. Chem. Lett., 24(17), 4239 – 4242 (2014).
S. M. Gomha, E. M. H. Abbas, and T. A. Farghaly, J. Heterocycl. Chem., 54, 610 – 617 (2017); doi: https://doi.org/10.1002/jhet.2632.
M. Y. Ebied, W. A. Zaghary, K. M. Amin, et al., J. Adv. Pharm. Res., 1(4), 216 – 227 (2017); doi: https://doi.org/10.21608/aprh.2017.4043.
C. Brullo, M. Rocca, P. Foss, et al., Bioorg. Med. Chem. Lett., 22(2), 1125 – 1129 (2012).
H. K. Maurya, R. Vema, S. Alam, et al., Bioorg Med. Chem. Lett., 23(21), 5844 – 5849 (2013).
A. I. Markosyan, Kh. S. Hakopyan, S. H. Gabrielyan, et al., Electron. J. Nat. Sci. NAS RA, 30(2), 39 – 42 (2018).
A. I. Markosyan, Kh. S. Hakopyan, A. S. Ayvazyan, et al., Chem. J. Arm., 71(4), 596 – 608 (2018).
A. I. Markosyan, A. S. Ayvazyan, S. A. Gabrielyan, et al., Khim.-farm. Zh., 54(5), 21 – 25 (2020); Pharm. Chem. J., 54(5), 449 – 454 (2020).
A. I. Markosyan, A. S. Ayvazyan, S. H. Gabrielyan, et al., Electron. J. Nat. Sci. NAS RA, 34(1), 22 – 27 (2020).
A. I. Markosyan, S. V. Dilanyan, S. H. Gabrielyan, et al., Electronic J. Nat. Sci. NAS RA, 27(2), 23 – 27 (2016).
A. I. Markosyan, K. K. Airapetyan, S. A. Gabrielyan, et al., Zh. Org. Khim., 54(4), 604 – 611 (2018).
A. I. Markosyan, S. V. Dilanyan, R. S. Sukasyan, et al., Khim.- farm. Zh., 42(3), 16 – 19 (2008); doi https://doi.org/10.30906/0023-1134-2008-42-3-16-19.
A. I. Markosyan, M. G. Oganisyan, R. A. Kuroyan, et al., Arm. Khim. Zh., 45(3–4), 208 – 211 (1992).
A. I. Markosyan, K. K. Airapetyan, S. A. Gabrielyan, et al., Khim. Zh. Arm., 71(3), 377 – 388 (2018).
A. I. Markosyan, A. S. Ayvazyan, S. H. Gabrielyan, et al., Chem. J. Arm., 72(4), 469 – 482 (2019).
A. I. Markosyan, A. S. Ayvazyan, S. H. Gabrielyan, et al., Khim.-farm. Zh., 55(2), 24 – 28 (2021); doi: 0.30906/0023-1134-2021-55-2-24-28; Pharm. Chem. J., 55(2), 133 – 137 (2020).
A. I. Markosyan, A. S. Ayvazyan, S. A. Gabrielyan, et al., Zh. Org. Khim., 57(3), 410 – 419 (2021); doi: 10.31857/S0514749221030095.
A. S. Ayvazyan, Khim. Zh. Arm., 74(1–2), 87 – 100 (2021).
A. S. Ayvazyan, Electron. J. Nat. Sci. NAS RA, 36(1), 26 – 30 (2021).
A. N. Mironov, Handbook for Preclinical Drug Studies [in Russian], Grif i K, Moscow (2012), pp. 509 – 524.
Z. P. Sof′ina, A. B. Syrkin, A. Goldin, et al., Experimental Assessment of Antitumor Drugs in the USSR and USA [in Russian], Meditsina, Moscow (1980).
Author information
Authors and Affiliations
Corresponding author
Additional information
Translated from Khimiko-Farmatsevticheskii Zhurnal, Vol. 56, No. 10, pp. 17 – 22, October, 2022.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Markosyan, A.I., Ayvazyan, A.S., Gabrielyan, S.A. et al. Synthesis, Some Transformations, and Biological Properties of 3-Phenethyl-2-Thioxo-2,3-Dihydro-1H-spiro[Benzo[H]Quinazoline-5,1′-Cycloheptane]-4(6H)-Ones. Pharm Chem J 56, 1321–1326 (2023). https://doi.org/10.1007/s11094-023-02792-6
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11094-023-02792-6